Subscribe

Hannover Rück SE (HNR1.DE)

EUR253.20 +1.20 (+0.48%)
DE XETRA Financial Services Insurance - Reinsurance
Address Karl-Wiechert-Allee 50 30625
Hanover, NI, DE
CEO Clemens Jungsthofel
Website hannover-re.com
IPO 2000-10-23
ISIN DE0008402215

Explore sections of this company profile

Also trades on Deutsche Börse · HNR1.DE (EUR) Other OTC · HVRRF (USD) Other OTC · HVRRY (USD) Swiss Exchange · HNR1.SW (EUR)
Description

Hannover Rück SE, along with its group entities, offers a broad spectrum of reinsurance products and services worldwide. Operations are structured around two principal segments: Property & Casualty Reinsurance, and Life & Health Reinsurance. Within Property & Casualty Reinsurance, its offerings span traditional property and casualty coverage, facultative arrangements, extensive catastrophe excess-of-loss protection, custom-tailored structured reinsurance, and innovative insurance-linked securities. The company further specializes in risk solutions for agriculture, livestock, bloodstock, aviation, space, marine, and offshore energy industries, in addition to providing coverage for credit, surety, and political risks. Its Life & Health Reinsurance segment encompasses a range of products including group and individual credit life, enhanced annuities, collective life and health schemes, and Takaful reinsurance. It also engineers risk solutions addressing critical illness, disability, general health, longevity, long-term care, mortality, and morbidity. Beyond its core reinsurance activities, the firm delivers diverse financial solutions, such as financing new business ventures, monetizing embedded value, providing reserve and solvency relief, and assisting with the divestiture of non-core operations. Founded in 1966, the company maintains its headquarters in Hanover, Germany. It was formerly known as Hannover Rückversicherung AG before rebranding to Hannover Rück SE in March 2013. Hannover Rück SE functions as a subsidiary of Talanx AG.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
EUR253.20 +1.20 (+0.48%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
176.6K
Beta
0.13
Float Shares
60.03M
Free Float %
49.8%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.26% -4.39% -14.10% -4.62% -9.89% -9.95% -11.78% +23.46% +61.10% +144.01% +672.67%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
253.20
DCF (Unlevered) 2,472.65 +876.6%
DCF (Levered) 4,485.04 +1,671.3%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 33% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 4 0
Hold 9 0
Sell 0 0
Strong Sell 1 0
Quality scores
Altman Z-Score
1.84
Grey zone
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Insurance - Reinsurance: +19.7%
    +909.3% ★ Q1'26: +945.3% (vs Q1'25)
  • ✓
    EPS growth Insurance - Reinsurance: +47.7%
    +13.4% Q1'26: +1,380.4% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Insurance - Reinsurance: +7.0%
    +9.5% Q1'26: +0.0% (vs Q1'25)
  • ✗
    EBIT margin Insurance - Reinsurance: +13.4%
    +0.0% Q1'26: +0.0% (vs Q1'25)
  • ✗
    ROIC Insurance - Reinsurance: +4.0%
    +0.0%
  • ✓
    Share dilution Insurance - Reinsurance: +0.2%
    +0.0% Q1'26: -0.1% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Insurance - Reinsurance: 0.00×
    —
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.14) × ERP
WACC = 87% × Ke + 13% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 2,427.90 Current price: 253.20
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2011
actual 		Dec 2012
actual 		Dec 2013
actual 		Dec 2014
actual 		Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
1 Rev. Ana.
12 EPS Ana. 		Dec 2027
8 Rev. Ana.
12 EPS Ana. 		Dec 2028
6 Rev. Ana.
12 EPS Ana. 		Dec 2029
5 Rev. Ana.
10 EPS Ana. 		Dec 2030
3 Rev. Ana.
5 EPS Ana.
Revenue
12.17B
est: 12.14B (+0.3%)
13.92B
est: 13.44B (+3.5%)
13.66B
est: 14.25B (-4.1%)
14.04B
est: 14.07B (-0.3%)
16.33B
est: 16.54B (-1.3%)
16.08B
est: 16.69B (-3.6%)
17.54B
est: 17.58B (-0.2%)
18.97B
est: 19.43B (-2.4%)
21.58B
est: 21.89B (-1.4%)
23.17B
est: 24.82B (-6.6%)
26.28B
est: 27.32B (-3.8%)
1.39B
est: 33.16B (-95.8%)
21.98B
est: 25.71B (-14.5%)
2.66B
est: 26.06B (-89.8%)
26.80B
est: 26.75B (+0.2%)
27.44B
27.19B – 27.71B
+2.6% YoY
28.58B
28.07B – 29.15B
+4.2% YoY
29.78B
29.64B – 29.92B
+4.2% YoY
30.97B
30.69B – 31.29B
+4.0% YoY
32.30B
32.00B – 32.62B
+4.3% YoY
EBITDA
893.00M
est: 960.36M (-7.0%)
1.52B
est: 642.54M (+136.8%)
1.34B
est: 1.24B (+7.7%)
1.58B
est: 939.32M (+68.6%)
1.87B
est: 1.49B (+25.7%)
1.76B
est: 1.60B (+10.1%)
1.40B
est: 1.69B (-17.2%)
1.71B
est: 1.40B (+21.8%)
1.99B
est: 1.63B (+22.2%)
1.44B
est: 1.89B (-24.1%)
1.71B
est: 2.03B (-15.6%)
1.44B
est: 2.13B (-32.3%)
2.01B
est: 11.09B (-81.9%)
3.37B
est: 11.23B (-70.0%)
—
est: 11.54B (-100.0%)
11.83B
11.73B – 11.95B
+2.6% YoY
12.33B
12.11B – 12.57B
+4.2% YoY
12.84B
12.78B – 12.91B
+4.2% YoY
13.36B
13.24B – 13.49B
+4.0% YoY
13.93B
13.80B – 14.07B
+4.3% YoY
EBIT
884.88M
est: 1.27B (-30.3%)
1.47B
est: 931.53M (+57.8%)
1.31B
est: 1.49B (-12.2%)
1.53B
est: 1.20B (+27.0%)
1.80B
est: 1.74B (+3.8%)
1.65B
est: 1.77B (-6.4%)
1.28B
est: 1.78B (-28.1%)
1.61B
est: 1.53B (+5.3%)
1.88B
est: 1.79B (+4.8%)
1.27B
est: 2.06B (-38.4%)
1.61B
est: 2.21B (-27.3%)
1.53B
est: 2.32B (-34.3%)
2.01B
est: 11.07B (-81.8%)
3.37B
est: 11.21B (-70.0%)
—
est: 11.52B (-100.0%)
11.81B
11.70B – 11.93B
+2.6% YoY
12.31B
12.09B – 12.55B
+4.2% YoY
12.82B
12.76B – 12.88B
+4.2% YoY
13.33B
13.21B – 13.47B
+4.0% YoY
13.90B
13.78B – 14.05B
+4.3% YoY
Net Income
605.97M
est: 809.76M (-25.2%)
849.59M
est: 671.23M (+26.6%)
895.47M
est: 908.25M (-1.4%)
985.65M
est: 874.27M (+12.7%)
1.15B
est: 1.17B (-1.4%)
1.17B
est: 1.16B (+1.1%)
958.56M
est: 1.24B (-22.5%)
1.06B
est: 1.07B (-1.4%)
1.28B
est: 1.19B (+7.9%)
883.07M
est: 1.43B (-38.2%)
1.23B
est: 1.53B (-19.6%)
780.80M
est: 1.55B (-49.7%)
1.82B
est: 2.03B (-9.9%)
2.33B
est: 2.37B (-1.7%)
2.64B
est: 2.64B (-0.1%)
2.78B
2.58B – 2.88B
+5.3% YoY
2.81B
2.56B – 2.99B
+1.1% YoY
2.90B
2.31B – 3.10B
+3.2% YoY
3.07B
3.04B – 3.11B
+6.0% YoY
3.22B
3.18B – 3.26B
+4.6% YoY
SGA
289.06M
est: 317.85M (-9.1%)
310.79M
est: 334.51M (-7.1%)
333.67M
est: 357.79M (-6.7%)
363.86M
est: 326.26M (+11.5%)
398.51M
est: 451.45M (-11.7%)
401.55M
est: 413.99M (-3.0%)
411.30M
est: 424.23M (-3.0%)
423.34M
est: 497.52M (-14.9%)
480.08M
est: 505.14M (-5.0%)
478.18M
est: 544.53M (-12.2%)
510.71M
est: 583.63M (-12.5%)
575.76M
est: 612.95M (-6.1%)
—
est: 2.23B (-100.0%)
—
est: 2.26B (-100.0%)
—
est: 2.32B (-100.0%)
2.38B
2.36B – 2.41B
+2.6% YoY
2.48B
2.44B – 2.53B
+4.2% YoY
2.59B
2.57B – 2.60B
+4.2% YoY
2.69B
2.67B – 2.72B
+4.0% YoY
2.81B
2.78B – 2.83B
+4.3% YoY
EPS
5.02
est: 4.71 (+6.5%)
7.04
est: 6.93 (+1.7%)
7.43
est: 7.05 (+5.4%)
8.17
est: 7.95 (+2.8%)
9.54
est: 8.48 (+12.6%)
9.71
est: 9.08 (+6.9%)
7.95
est: 7.27 (+9.3%)
8.79
est: 8.59 (+2.3%)
10.65
est: 10.74 (-0.8%)
7.32
est: 7.17 (+2.1%)
10.21
est: 10.11 (+1.0%)
6.47
est: 11.69 (-44.7%)
15.13
est: 16.80 (-9.9%)
19.31
est: 19.63 (-1.6%)
21.89
est: 21.73 (+0.7%)
23.01
21.41 – 23.89
+5.9% YoY
23.67
21.20 – 24.81
+2.9% YoY
24.57
19.17 – 25.69
+3.8% YoY
25.49
25.19 – 25.82
+3.7% YoY
26.67
26.35 – 27.02
+4.6% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 A- 4/5 5/5 5/5 5/5 3/5 2/5 1/5
2026-05-08 A 4/5 5/5 5/5 5/5 3/5 3/5 1/5
2026-05-07 A- 4/5 4/5 5/5 5/5 3/5 3/5 1/5
2026-05-06 A- 4/5 4/5 5/5 5/5 3/5 3/5 1/5
2026-05-05 A- 4/5 4/5 5/5 5/5 3/5 3/5 1/5
2026-05-04 A- 4/5 4/5 5/5 5/5 3/5 3/5 1/5
2026-04-30 A- 4/5 4/5 5/5 5/5 2/5 3/5 1/5
2026-04-29 A- 4/5 5/5 5/5 5/5 2/5 3/5 1/5
2026-04-28 A- 4/5 4/5 5/5 5/5 2/5 3/5 1/5
2026-04-27 A- 4/5 4/5 5/5 5/5 2/5 3/5 1/5
2026-04-24 A- 4/5 4/5 5/5 5/5 2/5 3/5 1/5
2026-04-23 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5
2026-04-22 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5
2026-04-21 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5
2026-04-20 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5
2026-04-17 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5
2026-04-16 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5
2026-04-15 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
4.08B
OE per share TTM
33.95
Owner's Yield
15.37%
Maintenance CapEx ratio
257.61%
Maint CapEx / Avg PPE
0.7%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
1
Total invested
22.68M
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2025 Q3
Investors holding
1
+0 vs prev Q
New positions
0
Closed positions
0
Increased
0
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
# Investor ⇅ Shares / Δ ⇅ Mkt value / Δ ⇅ Own% / Δ ⇅ Weight% / Δ ⇅ Avg px / Perf. ⇅ Hold / Status ⇅
1 BOSTON COMMON ASSET MANAGEMENT, LLC — -75.2K (-100.0%) — -22.7M (-100.0%) 0.00% -0.062 pp 0.00% -0.635 pp EUR— 11 qtrs SOLD
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
Shares Outstanding
120.60M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Silke Sehm Member of Executive Board 1M female
Sharon Ooi Member of Executive Board 1M female
Christian Hermelingmeier Chief Financial Officer & Member of Executive Board 1M —
Clemens Jungsthofel Chief Executive Officer & Chairman of the Executive Board 1M male
Brona Magee Member of the Executive Board 1M female
Claude Jacques Chèvre Member of the Executive Board 1M male
Sven Althoff Member of the Executive Board 1M male
Thorsten Steinmann Member of the Executive Board 1M male
Thomas Fiedler Managing Director & Chief Compliance Officer — —
Michael Eberhardt MD & Head of Hannover Re Australian Branch — male
Karl Steinle General Manager Investor & Rating Agency Relations — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Insurance - Reinsurance